Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell
出版年份 2012 全文链接
标题
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 9, Pages 2143-2152
出版商
Wiley
发表日期
2012-02-10
DOI
10.1002/ijc.27471
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Vivo Imaging of Human Malignant Mesothelioma Grown Orthotopically in the Peritoneal Cavity of Nude Mice
- (2012) Mingqian Feng et al. Journal of Cancer
- Targeting IGF-1R: throwing out the baby with the bathwater?
- (2011) B Basu et al. BRITISH JOURNAL OF CANCER
- Surgical Treatment of Malignant Pleural Mesothelioma
- (2011) Andrew J. Kaufman et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
- (2010) A Gualberto et al. BRITISH JOURNAL OF CANCER
- Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma
- (2010) David Olmos et al. CANCER JOURNAL
- Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy
- (2010) J. Zha et al. CLINICAL CANCER RESEARCH
- Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
- (2010) Diane Lauren Reidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines
- (2009) Kiyonori Kai et al. CANCER LETTERS
- Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
- (2009) Daniel D. Karp et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)
- (2009) Yixuan Gong et al. PLoS One
- Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody
- (2008) L. Cao et al. CANCER RESEARCH
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
- (2008) J. Rodon et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now